Novanta
NasdaqGS:NOVT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
WA
Consensus Narrative from 3 Analysts
New Product Launches Will Expand Presence In Precision Medicine And Robotics Automation
Key Takeaways Novanta anticipates substantial revenue growth in 2025 from new product launches and strong market trends in microelectronics and robotics automation. Benefits from secular growth in precision medicine and robotic surgery, along with strategic acquisitions, are expected to expand revenue streams and margins.
View narrativeUS$164.78
FV
14.7% undervalued intrinsic discount8.97%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
24 days ago author updated this narrative